Impact of proteasome inhibitor vs. IMiD maintenance therapy on outcomes of patients with high-risk multiple myeloma (HRMM).

被引：0
|
作者：
Tam, Eric Leon
Iberri, David Joseph
Liedtke, Michaela
Muffly, Lori S.
Shiraz, Parveen
Frank, Matthew Joshua
Lowsky, Robert
Rezvani, Andrew
Negrin, Robert
Meyer, Everett
Arai, Sally
Johnston, Laura J.
Shizuru, Judith
Weng, Wen-Kai
Miklos, David Bernard
Sidana, Surbhi
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20557
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Treatment options for multiple myeloma patients with high-risk disease
    Sikander Ailawadhi
    Aisha Masood
    Taimur Sher
    Kena C. Miller
    Margaret Wood
    Kelvin Lee
    Asher Chanan-Khan
    Medical Oncology, 2010, 27 : 53 - 61
  • [42] Genomic characterization of functional high-risk multiple myeloma patients
    Cinnie Yentia Soekojo
    Tae-Hoon Chung
    Muhammad Shaheryar Furqan
    Wee Joo Chng
    Blood Cancer Journal, 12
  • [43] DOUBLE-INTENSIVE THERAPY IN HIGH-RISK MULTIPLE-MYELOMA
    HAROUSSEAU, JL
    MILPIED, N
    LAPORTE, JP
    COLLOMBAT, P
    FACON, T
    TIGAUD, JD
    CASASSUS, P
    GUILHOT, F
    IFRAH, N
    GANDHOUR, C
    BLOOD, 1992, 79 (11) : 2827 - 2833
  • [44] Pacmed Salvage Therapy for Advanced High-Risk Multiple Myeloma (AHRMM)
    Alsayed, Yazan
    Waheed, Sarah
    Szymonifka, Jackie
    Nair, Bijay
    Usmani, Saad
    van Rhee, Frits
    Anaissie, Elias J.
    Grazziutti, Monica
    Hoering, Antje
    Barlogie, Bart
    BLOOD, 2010, 116 (21) : 822 - 823
  • [45] Carfilzomib, a next-generation proteasome inhibitor, from multiple myeloma to high cytogenetic risk
    Richez, Valentine
    Guidez, Stephanie
    Cayssials, Emilie
    Legros, Laurence
    Leleu, Xavier
    HEMATOLOGIE, 2016, 22 (05): : 305 - +
  • [46] Transplantation as salvage therapy for high-risk patients with myeloma in relapse
    C-K Lee
    B Barlogie
    M Zangari
    A Fassas
    E Anaissie
    C Morris
    F van Rhee
    M Cottler-Fox
    R Thertulien
    F Muwalla
    S Mazher
    A Badros
    G Tricot
    Bone Marrow Transplantation, 2002, 30 : 873 - 878
  • [47] Transplantation salvage therapy for high-risk patients with myeloma in relapse
    Lee, CK
    Barlogie, B
    Zangari, M
    Fassas, A
    Anaissie, E
    Morris, C
    van Rhee, F
    Cottler-Fox, M
    Thertulien, R
    Muwalla, F
    Mazher, S
    Badros, A
    Tricot, G
    BONE MARROW TRANSPLANTATION, 2002, 30 (12) : 873 - 878
  • [48] Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China
    Mei, Jiangang
    Zhai, Yongping
    Li, Hanqing
    Li, Feng
    Zhou, Xiaogang
    Song, Ping
    Zhao, Qian
    Yu, Yaping
    An, Zhiming
    Wang, Liping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (11) : 2263 - 2273
  • [49] Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China
    Jiangang Mei
    Yongping Zhai
    Hanqing Li
    Feng Li
    Xiaogang Zhou
    Ping Song
    Qian Zhao
    Yaping Yu
    Zhiming An
    Liping Wang
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2263 - 2273
  • [50] Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation
    Alsina, Melissa
    Becker, Pamela S.
    Zhong, Xiaobo
    Adams, Alexia
    Hari, Parameswaran
    Rowley, Scott
    Stadtmauer, Edward A.
    Vesole, David H.
    Logan, Brent
    Weisdorf, Daniel
    Qazilbash, Muzaffar
    Popplewell, Leslie L.
    McClune, Brian
    Bensinger, William
    Riches, Marcie
    Giralt, Sergio A.
    Pasquini, Marcelo C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1183 - 1189
12345